Genespire
Developer of transformative gene therapies designed to treat patients affected by severe genetic diseases. The company's therapies combine integration-defective lentiviral vectors with gene editing fo...
Valuation
$0
Share Price
N/A
Total Raised
$69.2M
Last Round
N/A